Catalyst Pharmaceuticals, Inc.
(CPRX - NASDAQ)
29,43 USD
📋 Profilo Aziendale

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.

|